Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis

被引:132
作者
Rogan, MP
Taggart, CC [1 ]
Greene, CM
Murphy, PG
O'Neill, SJ
McElvaney, NG
机构
[1] Royal Coll Surgeons Ireland, Beaumont Hosp, Pulm Res Div, Educ & Res Ctr,Dept Med, Dublin 9, Ireland
[2] Inc Natl Childrens Hosp Tallaght, Adelaide & Meath Hosp Dublin, Dept Microbiol, Dublin, Ireland
关键词
D O I
10.1086/423821
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Intractable formation of biofilm by and infection with the opportunistic pathogen Pseudomonas aeruginosa are hallmarks of cystic fibrosis (CF). Lactoferrin, an innate immunity protein, has recently been shown to inhibit the formation of P. aeruginosa biofilm. Partial cleavage of lactoferrin by the proteases neutrophil elastase and Pseudomonas elastase has previously been described in CF. Here, we show that cathepsins in CF secretions are responsible for complete and rapid cleavage of lactoferrin. We demonstrate that levels of lactoferrin in P. aeruginosa-positive sputum samples are decreased when corrected for inflammatory burden and that P. aeruginosa-positive sputum samples have significantly higher cathepsin activity and significantly reduced ability to inhibit formation of biofilm, compared with P. aeruginosa-negative sputum samples. We also show that cleavage of lactoferrin by cathepsin results in loss of both its microbicidal and antibiofilm activity. Loss of such a vital innate immunity protein clearly has important implications for the pathogenesis of chronic P. aeruginosa lung infection in patients with CF.
引用
收藏
页码:1245 / 1253
页数:9
相关论文
共 56 条
[1]   The effect of human lactoferrin on the MICs of doxycycline and rifampicin for Burkholderia cepacia and Pseudomonas aeruginosa strains [J].
Alkawash, M ;
Head, M ;
Alshami, I ;
Soothill, JS .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (03) :385-387
[2]  
[Anonymous], 1989, Eur Respir J, V2, P561
[3]   LACTOFERRIN IS A LIPID A-BINDING PROTEIN [J].
APPELMELK, BJ ;
AN, YQ ;
GEERTS, M ;
THIJS, BG ;
DEBOER, HA ;
MACLAREN, D ;
DEGRAAFF, J ;
NUIJENS, JH .
INFECTION AND IMMUNITY, 1994, 62 (06) :2628-2632
[4]   BACTERICIDAL ACTIVITY OF HUMAN LACTOFERRIN - DIFFERENTIATION FROM THE STASIS OF IRON DEPRIVATION [J].
ARNOLD, RR ;
RUSSELL, JE ;
CHAMPION, WJ ;
BREWER, M ;
GAUTHIER, JJ .
INFECTION AND IMMUNITY, 1982, 35 (03) :792-799
[5]   BACTERICIDAL EFFECT FOR HUMAN LACTOFERRIN [J].
ARNOLD, RR ;
COLE, MF ;
MCGHEE, JR .
SCIENCE, 1977, 197 (4300) :263-265
[6]   Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft model [J].
Bals, R ;
Weiner, DJ ;
Meegalla, RL ;
Wilson, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (08) :1113-1117
[7]   Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide [J].
Bals, R ;
Weiner, DJ ;
Moscioni, AD ;
Meegalla, RL ;
Wilson, JM .
INFECTION AND IMMUNITY, 1999, 67 (11) :6084-6089
[8]   TRANSFERRIN AND LACTOFERRIN UNDERGO PROTEOLYTIC CLEAVAGE IN THE PSEUDOMONAS AERUGINOSA-INFECTED LUNGS OF PATIENTS WITH CYSTIC-FIBROSIS [J].
BRITIGAN, BE ;
HAYEK, MB ;
DOEBBELING, BN ;
FICK, RB .
INFECTION AND IMMUNITY, 1993, 61 (12) :5049-5055
[9]   INFLUENCE OF GROWTH-RATE ON SUSCEPTIBILITY TO ANTIMICROBIAL AGENTS - MODIFICATION OF THE CELL-ENVELOPE AND BATCH AND CONTINUOUS CULTURE STUDIES [J].
BROWN, MRW ;
COLLIER, PJ ;
GILBERT, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (09) :1623-1628
[10]  
Burns J L, 1993, Adv Pediatr Infect Dis, V8, P53